Functional two-dimensional nanoarchitectures based on chemically converted graphene oxide and hematoporphyrin under the sulfuric acid treatment

Chemical Engineering Journal

Volumn 255, Issue , 2014, Pages 577-584

  Grinceviciute, N ^a   Snopok, B ^a,b   Snitka, V ^a  

^a KAUNAS UNIVERSITY OF TECHNOLOGY   (Lithuania)

^b INSTITUTE OF SEMICONDUCTOR PHYSICS   (Ukraine)

Author keywords

Drug delivery carrier; Esterification reaction; Graphene oxide; Hematoporphyrine; Nanocomposite; Raman scattering

Indexed keywords

DRUG DELIVERY; ESTERIFICATION; ESTERS; NANOCOMPOSITES; PHOTOSENSITIZERS; PORPHYRINS; RAMAN SCATTERING; SULFURIC ACID;

ABSORPTION AND EMISSIONS; CHEMICALLY CONVERTED GRAPHENE; DRUG DELIVERY CARRIER; ESTERIFICATION REACTIONS; FUNCTIONAL NANOCOMPOSITES; GRAPHENE OXIDES; HEMATOPORPHYRINE; SINGLET OXYGEN GENERATION;

GRAPHENE;

EID: 84904343625     PISSN: 13858947     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cej.2014.06.081     Document Type: Article

References (49)

1. Langer R. Drug delivery and targeting. Nature 1998, 392(6679 Suppl.):5-10.
2. Wang N.X., von Recum H.A. Affinity-based drug delivery. Macromol. Biosci. 2011, 11(3):321-332.
3. Ochekpe N.A., Olorunfemi P.O., Ngwuluka N.C. Nanotechnology and drug delivery part 2: nanostructures for drug delivery. Trop. J. Pharm. Res. 2009, 8(3).
4. Wilczewska A.Z., Niemirowicz K., Markiewicz K.H., Car H. Nanoparticles as drug delivery systems. Pharmacol. Rep. 2012, 64(5):1020-1037.
5. Allen T.M., Cullis P.R. Drug delivery systems: entering the mainstream. Science 2004, 303(5665):1818-1822.
6. Zhu Y., Murali S., Cai W., Li X., Suk J.W., Potts J.R., Ruoff R.S. Graphene and graphene oxide: synthesis, properties, and applications. Adv. Mater. 2010, 22(35):3906-3924.
7. Shen H., Zhang L., Liu M., Zhang Z. Biomedical applications of graphene. Theranostics 2012, 2(3):283.
8. Zhang X., Yin J., Peng C., Hu W., Zhu Z., Li W., Huang Q. Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration. Carbon 2011, 49(3):986-995.
9. Zhang Nan, Zhang Yanhui, Xu Yi-Jun Recent progress on graphene-based photocatalysts: current status and future perspectives. Nanoscale 2012, 4(19):5792-5813.
10. Yang Min-Quan, Yi-Jun Xu Selective photoredox using graphene-based composite photocatalysts. Phys. Chem. Chem. Phys. 2013, 15(44):19102-19118.
11. Liu Z., Robinson J.T., Sun X., Dai H. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J. Am. Chem. Soc. 2008, 130(33):10876-10877.
12. Feng L., Liu Z. Graphene in biomedicine: opportunities and challenges. Nanomedicine 2011, 6(2):317-324.
13. Liu J., Cui L., Losic D. Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater. 2013, 9(12):9243-9257.
14. Miao W., Shim G., Lee S., Lee S., Choe Y.S., Oh Y.K. Safety and tumor tissue accumulation of pegylated graphene oxide nanosheets for co-delivery of anticancer drug and photosensitizer. Biomaterials 2013, 34(13):3402-3410.
15. Yan L., Chang Y.N., Zhao L., Gu Z., Liu X., Tian G., Zhao Y. The use of polyethylenimine-modified graphene oxide as a nanocarrier for transferring hydrophobic nanocrystals into water to produce water-dispersible hybrids for use in drug delivery. Carbon 2013, 57:120-129.
16. Gao Y., Zou X., Zhao J.X., Li Y., Su X. Graphene oxide-based magnetic fluorescent hybrids for drug delivery and cellular imaging. Colloids Surf. B 2013, 112:128-133.
17. Zhang L., Xia J., Zhao Q., Liu L., Zhang Z. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 2010, 6(4):537-544.
18. Yang X., Zhang X., Liu Z., Ma Y., Huang Y., Chen Y. High-efficiency loading and controlled release of doxorubicin hydrochloride on graphene oxide. J. Phys. Chem. C 2008, 112(45):17554-17558.
19. Yang X., Wang Y., Huang X., Ma Y., Huang Y., Yang R., Chen Y. Multi-functionalized graphene oxide based anticancer drug-carrier with dual-targeting function and pH-sensitivity. J. Mater. Chem. 2011, 21(10):3448-3454.
20. Zhang Q., Li W., Kong T., Su R., Li N., Song Q., Cheng G. Tailoring the interlayer interaction between doxorubicin-loaded graphene oxide nanosheets by controlling the drug content. Carbon 2012, 51:164-172.
21. Ye T.X., Ye S.L., Chen D.M., Chen Q.A., Qiu B., Chen X. Spectroscopic characterization of tetracationic porphyrins and their noncovalent functionalization with graphene. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2012, 86:467-471.
22. Liu Z.B., Xu Y.F., Zhang X.Y., Zhang X.L., Chen Y.S., Tian J.G. Porphyrin and fullerene covalently functionalized graphene hybrid materials with large nonlinear optical properties. J. Phys. Chem. B 2009, 113(29):9681-9686.
23. Dong H., Zhao Z., Wen H., Guo F., Shen A., Pilger F., Shi D. Poly (ethylene glycol) conjugated nano-graphene oxide for photodynamic therapy. Sci. China Chem. 2010, 53(11):2265-2271.
24. Banfi S., Caruso E., Zaza S., Mancini M., Gariboldi M.B., Monti E. Synthesis and photodynamic activity of a panel of BODIPY dyes. J. Photochem. Photobiol., B 2012, 114:52-60.
25. Krieg M., Whitten D.G. Self-sensitized photooxidation of protoporphyrin IX and related free-base porphyrins in natural and model membrane systems. Evidence for novel photooxidation pathways involving amino acids. J. Am. Chem. Soc. 1984, 106(8):2477-2479.
26. Moan J., Kessel D. Photoproducts formed from photofrin II in cells. J. Photochem. Photobiol. B 1988, 1(4):429-436.
27. Rotomskis R., Streckyte G., Bagdonas S. Phototransformations of sensitizers 2. Photoproducts formed in aqueous solutions of porphyrins. J. Photochem. Photobiol., B 1997, 39(2):172-175.
28. Xie W., Wei S., Liu J., Ge X., Zhou L., Zhou J., Shen J. Combination anticancer therapy activity studies for the complex of hypocrellin A and gallium ion. Dyes Pigm. 2014, 101:43-50.
29. Luzgina V.N., Filippovich E.I., Evstigneeva R.P. Hematoporphyrin IX. Pharm. Chem. J. 1977, 11(5):613-620.
30. Strecker E.A., Palmer H., Braceland F.J. Hematoporphyrin as a therapeutic agent in the psychoses. Am. J. Psychiatry 1934, 90(6):1157-1173.
31. Rassmussen-Taxdal D.S., Ward G.E., Figge F.H. Fluorescence of human lymphatic and cancer tissues following high doses of intravenous hematoporphyrin. Cancer 1955, 8(1):78-81.
32. Dolmans D.E., Fukumura D., Jain R.K. Photodynamic therapy for cancer. Nat. Rev. Cancer 2003, 3(5):380-387.
33. Kotkowiak M., Lukasiewicz J., Dudkowiak A. Photophysical and thermodynamic parameters of hematoporphyrin in solutions and monolayers. Int. J. Thermophys. 2012, 1-9.
34. Schwartz S., Absolon K., Vermund H. Some relationships of porphyrins, X-rays and tumors. Univ. Minn. Med. Bull. 1955, 27:7-8.
35. Lipson R.L., Baldes E.J., Olsen A.M. The Use of a derivative of hematoporphyrin in tumor detection. JNCI 1961, 26:1-8.
36. Marchetti J.M., Errazu A.F. Esterification of free fatty acids using sulfuric acid as catalyst in the presence of triglycerides. Biomass Bioenergy 2008, 32(9):892-895.
37. Deng Y., Shi F., Beng J., Qiao K. Ionic liquid as a green catalytic reaction medium for esterifications. J. Mol. Catal. A: Chem. 2001, 165(1):33-36.
38. Naumenko D., Snitka V., Serviene E., Bruzaite I., Snopok B. In vivo characterization of protein uptake by yeast cell envelope: single cell AFM imaging and μ-tip-enhanced Raman scattering study. Analyst 2013, 138(18):5371-5383.
39. Snopok B.A., Boltovets P.N., Rowell F.J. Simple analytical model of biosensor competition analysis for detection of low-molecular-weight analytes. Theoret. Exp. Chem. 2006, 42(2):106-112.
40. Yang Y.T., Chen C.T., Tsai T. Absorption and fluorescence spectral properties of hematoporphyrin in liposomes, micelles, and nanoparticles. Dyes Pigment 2012, 96(3):763-769.
41. Shang J., Ma L., Li J., Ai W., Yu T., Gurzadyan G.G. The origin of fluorescence from graphene oxide. Sci. Rep. 2012, 2.
42. Kudin K.N., Ozbas B., Schniepp H.C., Prud'Homme R.K., Aksay I.A., Car R. Raman spectra of graphite oxide and functionalized graphene sheets. Nano Lett. 2008, 8(1):36-41.
43. Su C., Acik M., Takai K., Lu J., Hao S.J., Zheng Y., Loh K.P. Probing the catalytic activity of porous graphene oxide and the origin of this behaviour. Nat. Commun. 2012, 3:1298.
44. T.J. Dougherty, W.R. Potter, K.R. Weishaupt, (1989). U.S. Patent No. 4,866,168. Washington, DC: U.S. Patent and Trademark Office.
45. Chen J.L., Yan X.P. A dehydration and stabilizer-free approach to production of stable water dispersions of graphene nanosheets. J. Mater. Chem. 2010, 20(21):4328-4332.
46. Smith K.M. Porphyrins and Metalloporphyrins 1975, Elsevier Scientific Publishing Co.
47. Nicolaï A., Zhu P., Sumpter B.G., Meunier V. Molecular dynamics simulations of graphene oxide frameworks. J. Chem. Theory Comput. 2013, 9(11):4890-4900.
48. Tian B., Wang C., Zhang S., Feng L., Liu Z. Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ACS Nano 2011, 5(9):7000-7009.
49. M. Wojtoniszak, Graphene/graphene oxide-multifunctional platform for drug delivery and photodynamic therapy in cancer treatment.